# Feature Delivery Contract (Feature Specification Template)

## Document Metadata
*   **Document ID**: LIMS-DOC-17
*   **Version**: 1.0.0
*   **Author**: Antigravity (LIMS Solution Architect)
*   **Status**: Approved
*   **Last Updated**: 2026-07-04
*   **Dependencies**:
    *   [LIMS-DOC-05: User Roles & Permissions Matrix](file:///d:/Projects/Micro_Lab/docs/05_user_roles_permissions.md)
    *   [LIMS-DOC-06: End-to-End Lab Workflow](file:///d:/Projects/Micro_Lab/docs/06_end_to_end_workflow.md)
    *   [LIMS-DOC-13: UI/UX Foundation](file:///d:/Projects/Micro_Lab/docs/13_ui_ux_foundation.md)
    *   [LIMS-DOC-13A: UI State Dictionary](file:///d:/Projects/Micro_Lab/docs/13a_ui_state_dictionary.md)
    *   [LIMS-DOC-13B: Interaction Pattern Library](file:///d:/Projects/Micro_Lab/docs/13b_interaction_pattern_library.md)
    *   [LIMS-DOC-14: Component Library Specs](file:///d:/Projects/Micro_Lab/docs/14_component_library.md)
    *   [LIMS-DOC-15: Design System](file:///d:/Projects/Micro_Lab/docs/15_design_system.md)
    *   [LIMS-DOC-16: Enterprise Engineering Architecture](file:///d:/Projects/Micro_Lab/docs/16_enterprise_engineering_architecture.md)
    *   [LIMS-DOC-16A: AI Development Playbook](file:///d:/Projects/Micro_Lab/docs/16a_ai_development_playbook.md)
*   **Required By**:
    *   All Future Functional Module Specifications (Patient, Specimen, Culture, AST, Reports, Billing, etc.)
*   **Requested By**: Product Management & engineering Leadership
*   **Reviewed By**: Solution Architect & Lead Developer
*   **Approved By**: User
*   **Approval Date**: 2026-07-04

> **Scope Boundary**: This document defines the **structure, template placeholders, and compliance gates for individual LIMS features**. It is a layout blueprint and contract. It does **not** document specific LIMS modules (like Patient or AST details) or contain programming code (such as JavaScript, SQL, or HTML syntax). Individual functional specifications will use this template to document features.

---

## Purpose

The purpose of this document is to serve as the **Feature Delivery Contract** for the Microbiology LIMS. It establishes the mandatory, uniform template structure that every future module, epic, and feature must complete before development. By standardizing feature specifications across 24 structured dimensions (covering classification, UI/UX boundaries, backend logic, schemas, security, risks, and post-release validation), this contract guarantees that no undocumented code or visual styles enter the codebase, enforcing complete traceability from business requirement to production.

---

## Scope

This document covers:
*   The 24-section template schema that all future feature specifications must follow.
*   Classification frameworks for feature type, priority, complexity, and status.
*   Mapping layouts for user journeys, workflows, UI components, APIs, and databases.
*   Assessments for business impact, technical dependencies, risk, and reusability.
*   Verification checklists for quality gates, UAT, production readiness, and post-release validation.
*   The Feature Lifecycle and Governance Matrix.
*   Mandatory Feature Governance Rules.

---

## Main Content

---

### [NEW FEATURE SPECIFICATION TEMPLATE START]

*Below is the standard, reusable template format. Every feature specification document must populate all sections without modification to the headings or structure.*

---

## 1. Feature Information

*   **Feature ID**: FSPEC-[Module]-[Number] (e.g. FSPEC-AST-001)
*   **Feature Name**: [Descriptive Title]
*   **Document Version**: [e.g. 1.0.0]
*   **Status**: [Proposed / Approved / In Development]
*   **Dependencies**: [Prerequisite FSPEC IDs or architecture documents]
*   **Target Release**: [e.g. MVP Milestone 3]

---

## 2. Feature Classification

Every feature specification must categorize the target scope using the following classifications:

*   **Feature Type**:
    *   *Core Clinical*: Susceptibility calculations, growth observations, organism identifications.
    *   *Laboratory*: Receipt bench intake, plate inoculations, incubator shelving logs.
    *   *Administration*: User profile creation, printer settings configurations.
    *   *Reporting*: Validated PDF compilation, delivery notification dispatch.
    *   *Integration*: EHR interface adapters, external LIS query channels.
    *   *Security*: MFA setup, session locks.
    *   *Platform*: Workspace grids layouts, global search index runs.
    *   *Infrastructure*: Environment setup templates, automated logs backups.
*   **Priority**:
    *   *Critical*: Clinically significant or workflow-blocking actions (e.g. critical value overrides, pathologist sign-off).
    *   *High*: Core operational actions (e.g. specimen quality receipt checks).
    *   *Medium*: Auxiliary functional items (e.g. recent searches history logs).
    *   *Low*: Minor visual adjustments or personalization options.
*   **Complexity**:
    *   *Small*: Minor adjustment confined to a single component or API route (estimated < 1 day development).
    *   *Medium*: Core task update involving one screen, its component states, and database fields (estimated < 3 days).
    *   *Large*: Multi-screen clinical task involving state transitions and integrations (estimated 3–5 days).
    *   *Epic*: Large modular expansion introducing new business domain boundaries (estimated > 5 days).
*   **MVP Status**:
    *   *MVP*: Core feature required for paperless lab operations (Section 2, MVP Success Criteria).
    *   *Phase 2*: Non-critical clinical extensions or advanced automation interfaces.
    *   *Future*: Long-term SaaS scaling, predictive analytics, or instrument telemetry.

---

## 3. Functional Overview

*   **Purpose**: [Explain what problem this feature solves and why it is needed.]
*   **Expected Outcome**: [Describe the final state of the user interface and system behavior when the action completes.]
*   **Business Value**: [Detail the operational benefit (e.g. reduces specimen processing time by 15%, eliminates paper transcription steps).]
*   **Success Criteria**: [Define measurable criteria that prove the feature achieves its goals.]

---

## 4. Business Impact Assessment

*   **Business Problem**: [What clinical or laboratory issue is being addressed?]
*   **Expected Benefits**: [List tangible benefits: time saved, error rates reduced, audit trail clarity.]
*   **Target Users**: [Roles from LIMS-DOC-05 that will use the feature (e.g. Technician, Senior Microbiologist).]
*   **Operational Impact**: [How does this feature modify existing bench workflows?]
*   **Compliance Impact**: [Describe CLIA, HIPAA, or CAP validation requirements.]
*   **Clinical Safety Impact**: [How does this feature protect patients from diagnostic errors (e.g., duplicate entries, incorrect breakpoint matching)?]
*   **Success Metrics**: [How will performance be audited post-release? (e.g. turn-around-time limits, override frequency).]

---

## 5. User Journey & Workflow Mapping

```
Entry Point ──> Primary User Flow ──> Exit Point
                     │
                     ▼
               Exception Flow (EXC-xxx)
```

*   **Entry Point**: [Where does the user begin the task? (e.g. Dashboard worklist row click, receipt scan).]
*   **User Flow**: [Step-by-step description of user actions and system feedback.]
*   **Exit Point**: [How does the task end? (e.g. form submitted, state advanced, redirect to worklist).]
*   **Exception Flow**: [Describe deviation paths (e.g. unreadable barcodes, broken incubators). Reference EXC-001 through EXC-004 IDs.]
*   **Workflow Mapping**: [Reference the Workflow ID (WF-001 to WF-018) and Business Event (EVT-001 to EVT-014) from LIMS-DOC-06.]

---

## 6. UI Architecture Mapping

*   **Screen IDs**: [Traced screen ID from LIMS-DOC-13 Screen Inventory (e.g. SCR-009).]
*   **Layout Pattern**: [Layout A, B, C, or D from LIMS-DOC-13, Section 6.]
*   **Component IDs**: [Reusable components from LIMS-DOC-14 (e.g. CMP-804 AST Matrix, CMP-604 Context Bar).]
*   **UI States**: [Mapped UI States from LIMS-DOC-13A (e.g. Pristine, Dirty, Valid, Locked).]
*   **Interaction Patterns**: [Mapped interaction patterns from LIMS-DOC-13B (e.g. IP-FORM-04 Save, IP-DIALOG-04 Critical Dialog).]

---

## 7. Backend Architecture Mapping

*   **Required Services**: [Application services, domain services, or handlers involved in executing the task.]
*   **Business Rules**: [Reference BRS/SRS requirements governing the business logic (e.g. S/I/R calculations).]
*   **Events**: [Business Event IDs (EVT-xxx) fired by the backend on completion.]
*   **Background Processing**: [Identify any long-running tasks pushed to background queues (e.g. PDF compiling, email alerts).]
*   **Integrations**: [API channels or external system integrations involved.]

---

## 8. Database Impact Matrix

| Action | Schema/Table | Columns Modified/Added | Index Changes | Audit Log Impact |
| :--- | :--- | :--- | :--- | :--- |
| *e.g. Update* | `clinical.specimens` | `status`, `received_by`, `received_at` | Add index on `received_at` | Write event `EVT-003` |
| | | | | |

*   **Migration Requirements**: [Describe migration scripts needed, initial seeding constraints, and tenant isolation schema adjustments.]

---

## 9. Dependency Matrix

*   **Upstream Dependencies**: [Features or database tables that must exist before this feature can function.]
*   **Downstream Dependencies**: [Features or reporting outputs that depend on this feature.]
*   **Blocking Features**: [Prerequisite features prioritized in development.]
*   **Optional Dependencies**: [Non-blocking features or configurations.]
*   **External Systems**: [EHRs, LIS systems, barcode printer drivers, or lab instrumentation.]
*   **Shared Components**: [Reusable Layer 2/3 UI elements utilized.]
*   **Shared Services**: [Shared authentication, logging, or auditing utilities.]

---

## 10. Security Review Audit

*   **Authentication**: [Session JWT checks, credential re-verification prompts (IP-DIALOG-04).]
*   **Authorization (RBAC)**: [Specific roles permitted to view or execute (LIMS-DOC-05).]
*   **Sensitive Data**: [Identify PHI, demographic fields, or cryptographic keys. Verify AES-256 database column encryption.]
*   **Audit Events**: [Actions logged in the audit tables (actor, action description, timestamp, IP address).]
*   **Data Retention**: [State retention limits (e.g. 7 years) and disposal rules.]

---

## 11. Performance Expectations (SLAs)

*   **Page Load Time**: [Target limit in seconds (SLA matching LIMS-DOC-16, Section 13).]
*   **Search/Query Time**: [Target query timeout limit.]
*   **Save/Persistence Time**: [Target save button disable timeout.]
*   **Report Generation Time**: [Background queue latency target.]

---

## 12. Error Handling & Recovery

*   **Validation Errors**: [List input validation rules and error codes returned (e.g., ERR-003).]
*   **Business Errors**: [Domain rule violations and error codes (e.g., ERR-004).]
*   **Technical Errors**: [System/DB timeouts and error codes (e.g., ERR-008).]
*   **Recovery Strategy**: [Describe retry mechanisms, draft saving fallbacks, or offline caching options.]

---

## 13. Reusability Assessment

*   **UI Components**: [Can existing LIMS-DOC-14 components be reused? If not, justify why.]
*   **Workflows**: [Can existing LIMS-DOC-06 status transition schemas be reused?]
*   **APIs**: [Can existing endpoint schemas or DTO interfaces be reused?]
*   **Validations**: [Can shared validation rules be reused?]
*   **Business Rules**: [Can existing calculation utilities or taxonomies be reused?]

---

## 14. Deployment Readiness Checklist

- [ ] **Documentation Complete**: Specification is approved. API schemas are documented in the registry.
- [ ] **Tests Complete**: Unit test coverage > 85%. E2E regression tests pass.
- [ ] **QA Complete**: Verified against acceptance criteria.
- [ ] **UAT Complete**: Signed off by lead clinical stakeholder.
- [ ] **Rollback Plan**: Deployment script includes version rollback path.
- [ ] **Monitoring Ready**: Health probes and SLA triggers are configured.

---

## 15. Feature Traceability Chain

Every feature specification must prove alignment to previous deliverables:
*   *Product Vision Link*: Traces to [LIMS-DOC-01, Section X]
*   *BRS Requirement Link*: Traces to [LIMS-DOC-03, REQ-BRS-XX]
*   *SRS Requirement Link*: Traces to [LIMS-DOC-04, REQ-SRS-XX]
*   *Workflow ID*: WF-[XX] (LIMS-DOC-06)
*   *Screen ID*: SCR-[XX] (LIMS-DOC-13)
*   *Component ID*: CMP-[XX] (LIMS-DOC-14)
*   *API Standard*: Traces to [LIMS-DOC-16, Section 7]
*   *Database Standard*: Traces to [LIMS-DOC-16, Section 8]
*   *Test Case ID*: TC-[Module]-[Number]

---

## 16. Feature Lifecycle

Features progress through a structured 12-stage lifecycle. Each transition is governed by strict entry and exit criteria.

```
Proposed ──> Approved ──> Planned ──> In Development ──> Code Review ──> QA
                                                                          │
Retired  <── Deprecated <── Stable <──  Monitoring  <──  Released  <── UAT
```

1.  **Proposed**: Feature request is logged in the product backlog.
    *   *Exit Criteria*: Product Owner signs off on feature priority.
2.  **Approved**: Technical feasibility is checked.
    *   *Exit Criteria*: This Feature Delivery Contract is completed and approved.
3.  **Planned**: Feature is prioritized for a sprint.
    *   *Exit Criteria*: Development tasks are assigned to engineers.
4.  **In Development**: Code is written and local unit tests pass.
    *   *Exit Criteria*: Pull Request is raised with passing local build checks.
5.  **Code Review**: Peer code review and security audits are complete.
    *   *Exit Criteria*: Two approvals signed off, PR merges to develop branch.
6.  **QA**: Integration and regression testing are complete.
    *   *Exit Criteria*: QA Lead signs off on build quality.
7.  **UAT**: Users validate workflow usability.
    *   *Exit Criteria*: Business stakeholders sign off on UAT checklist.
8.  **Released**: Production deployment compiles.
    *   *Exit Criteria*: Smoke tests pass in the live production database.
9.  **Monitoring**: SRE tracks logs and SLA turn-around-times.
    *   *Exit Criteria*: Feature meets SLA metrics for 30 consecutive days.
10. **Stable**: Feature operates with no critical bugs.
    *   *Exit Criteria*: Transits to Deprecated if superseded by updates.
11. **Deprecated**: Feature is marked for replacement in future milestones.
    *   *Exit Criteria*: Replaced entirely by new version.
12. **Retired**: Code is removed from repositories.
    *   *Exit Criteria*: System verification confirms no downstream dependencies are broken.

---

## 17. Risk Assessment

Identify potential feature failure points and mitigations:

| Risk Category | Risk Description | Probability (L/M/H) | Impact (L/M/H) | Mitigation Strategy | Owner |
| :--- | :--- | :---: | :---: | :--- | :--- |
| **Functional** | *e.g. Technician enters zone values incorrectly* | M | H | Enforce range validations (6-50mm) inside input fields | Lead Tech |
| **Technical** | *e.g. Dilution matrix calculation timeout* | L | H | Run calculations in background queue | SRE |
| **Security** | *e.g. Unauthorized override of S/I/R output* | L | H | Require digital signature validation modal | Admin |
| **Performance**| *e.g. Report PDF generation latency exceeds SLA*| M | M | Stream PDF files via object storage repositories | SRE |
| **Operational**| *e.g. Printer offline blocks barcode label printing*| M | H | Queue label print tasks; show visual warning banners | QA Lead |

---

## 18. Production Readiness Assessment

Before production deployment is approved, the feature must satisfy this 10-point checklist:

- [ ] **Documentation Complete**: Feature specs are merged. Wikis and user manuals are updated.
- [ ] **UI Approved**: Screen alignment matches LIMS-DOC-15 Design System.
- [ ] **Backend Approved**: APIs follow LIMS-DOC-16 kebab REST naming conventions.
- [ ] **Database Approved**: Migrations, audit columns, and tenant partition columns are checked.
- [ ] **Tests Passed**: Unit test coverage exceeds 85%. E2E regression tests pass.
- [ ] **Security Review Passed**: JWT routing checks are verified. No vulnerability warnings.
- [ ] **Accessibility Review Passed**: Keyboard tab focus cycle passes checks.
- [ ] **Performance Targets Met**: Load and query benchmarking fits within SLA targets.
- [ ] **Monitoring Configured**: `/health` endpoints check database connectivity.
- [ ] **Rollback Strategy Available**: Container configurations include automated rollback paths.

---

## 19. Post-Release Validation

*   **Production Verification Steps**: [Describe step-by-step checks to execute post-deployment.]
*   **Health Checks**: [List health probes and database tests used to check feature health.]
*   **KPI Monitoring**: [Track metrics (e.g. transaction count, page latency).]
*   **User Feedback Collection**: [Describe how technician or supervisor feedback is collected.]
*   **Defect Monitoring**: [SOP for tracking defects logged during launch.]
*   **Hypercare Period**: [Enforce a 7-day hypercare period where developers review logs daily.]
*   **Completion Criteria**: [Define when the feature moves from Released to Stable (e.g. 7 days with zero critical bugs).]

---

## 20. Feature Metrics

Metrics are logged to verify feature adoption and operational compliance:

*   *Adoption Rate*: Number of unique active users utilizing the feature weekly.
*   *Average Completion Time*: Average turn-around-time from feature task entry to exit.
*   *Error Rate*: Percentage of form submissions returning validation or server errors.
*   *Performance SLA*: Percentage of page requests loaded within SLA time targets.
*   *User Satisfaction*: Direct feedback ratings collected from laboratory staff surveys.
*   *Defect Rate*: Number of bugs logged against the feature post-release.
*   *Support Tickets*: Incident tickets opened per week.
*   *Business Outcome*: Measured business value (e.g. time saved, paper usage reduced).

---

## 21. Reusability Assessment Checklist

- [ ] **UI Component Reuse**: Checked against CMP-101 to CMP-813.
- [ ] **Workflow Reuse**: State transitions leverage existing WF paths.
- [ ] **API Endpoint Reuse**: Request/Response structures reuse existing DTOs.
- [ ] **Validation Code Reuse**: Shared validations in `shared/validation` are imported.
- [ ] **Business Logic Reuse**: Calculation packages are consolidated in utility libraries.

---

## 22. Governance Matrix

The governance matrix outlines the roles and reviews required across the feature delivery lifecycle:

| Feature Activity | Responsible Role | Approver | Required Documents | Quality Gates | Exit Criteria |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Requirements** | Product Owner | Product Owner | BRS / SRS | Consistency checks | Story marked "Ready" |
| **Design / UX** | UX Designer | UX Lead | mockups | Accessibility contrast | Layout signed off |
| **Specification**| Solution Architect | Solution Architect | LIMS-DOC-17 FSPEC | Traceability check | Contract approved |
| **Database Schema**| Developer | Database Admin | Migration DDL | Schema naming review | Script approved |
| **Development** | Developer | Lead Developer | PR code branch | Code compilation check| PR raised |
| **Code Review** | Peer Reviewer | Lead Developer | PR review comments | SOLID/DRY check | PR approved for merge |
| **QA Testing** | QA Engineer | QA Lead | Test reports | Unit coverage > 85% | QA signed off |
| **UAT Validation**| Lead Technician | Stakeholder | UAT sign-off check | Usability verification| Stakeholder signed off|
| **Release** | DevOps Engineer | SRE Lead | Release logs | Smoke test checks | Production verified |

---

## 23. Feature Approval Workflow

Every feature specification must progress through the following sequential sign-off gates before code integration:

```
1. BUSINESS SIGN-OFF (Product Owner approves BRS/SRS alignment)
   │
2. ARCHITECTURE SIGN-OFF (Solution Architect signs off on FSPEC-17 compliance)
   │
3. UX SIGN-OFF (UX Lead signs off on mockup and LIMS-DOC-15 compliance)
   │
4. ENGINEERING SIGN-OFF (Lead Developer approves API/DB/PR boundaries)
   │
5. QA SIGN-OFF (QA Lead signs off on automated test coverage)
   │
6. UAT SIGN-OFF (Lead Microbiologist approves interface workflows)
   │
7. PRODUCTION SIGN-OFF (SRE Lead signs off on deployment smoke tests)
```

No developer is permitted to write code for a feature until Gates 1, 2, and 3 are signed off. No code is merged until Gates 4 and 5 are completed.

---

## 24. Mandatory Feature Governance Rules

The following rules are mandatory and binding on all development, design, testing, and operations activities:

1.  **No feature may bypass the Feature Delivery Contract (LIMS-DOC-17). Every feature specification must complete every mandatory section, satisfy all quality gates, maintain full traceability, and receive all required approvals before implementation and production release.**
2.  **No feature may begin implementation unless all prerequisite UX, product, and architecture documents are approved and checked into the repository.**
3.  **Any proposed changes to feature behavior, data schemas, or component structures require updating the corresponding Feature Specification document (LIMS-DOC-17) and securing approval before coding begins.**
4.  **No pull request may be merged if it contains visual styles, data columns, or logic pathways that are not documented in the approved Feature Specification.**
5.  **Every test case, API endpoint, database migration script, and component code block must be trace-linked back to the Feature ID (`FSPEC-Module-Number`).**

---

### [NEW FEATURE SPECIFICATION TEMPLATE END]

---

## Review Checklist
- [x] Includes all 24 sections defined in the implementation plan.
- [x] Formulates a complete, reusable Feature Specification Template.
- [x] Specifies the 8 Feature Classification types, priorities, and complexities.
- [x] Details Functional Overview parameters (Purpose, Outcome, Business Value).
- [x] Integrates User Journey mappings linked to approved workflow IDs.
- [x] Traces layout components, API endpoints, and database tables to approved standards.
- [x] Details Business Impact and Reusability assessments.
- [x] Defines the 12-stage Feature Lifecycle with entry and exit criteria.
- [x] Includes a Risk Assessment matrix mapping functional, technical, and operational risks.
- [x] Establishes a 10-point Production Readiness and Post-Release validation protocol.
- [x] Defines 8 Feature KPI Metrics (Adoption, Error rates, SLA, etc.).
- [x] Formulates the 9-column Governance Matrix mapping responsibilities.
- [x] Details the 7-stage sequential Feature Approval Workflow.
- [x] Integrates the Mandatory Feature Governance Rules.
- [x] Verifies that the document contains no code snippets.
- [x] Traces design rules back to LIMS-DOC-05, -06, -13, -13A, -13B, -14, -15, and -16.
- [x] Follows the LIMS-DOC template structure.
